Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and Simvastatin in Impaired Glucose Tolerance
NCT00306826Phase 4Withdrawn
- Sponsor
- Leipzig University
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pioglitazone and simvastatin in impaired glucose tolerance (IGT) (3 arms), sponsored by Leipzig University. Primary endpoint: Change in intima media thickness of carotid artery. Status: withdrawn.
02
Drugs
pioglitazonesimvastatin
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00306826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306826.